Feasibility of a randomized controlled trial of symptom screening and feedback to healthcare providers compared with standard of care using the SPARK platform.

Sadie CookEmily VetteseGeorge A TomlinsonDilip SomanTal SchechterSusan KuczynskiBrenda GladstoneL Lee DupuisLillian Sung

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2019)

A randomized trial of the SPARK with daily symptom screening for 5 days was feasible. It is now appropriate to proceed toward a definitive multi-center trial to test the efficacy of SPARK to improve symptom control.

Keyphrases

healthcare
patient reported
clinical trial
study protocol
palliative care
high throughput
randomized controlled trial
phase iii
squamous cell carcinoma
locally advanced
chronic pain
open label